INCREASE OF THE BRAIN UPTAKE INDEX FOR L-ORNITHINE IN RATS WITH HEPATIC-ENCEPHALOPATHY

被引:22
作者
ALBRECHT, J [1 ]
HILGIER, W [1 ]
JANUSZEWSKI, S [1 ]
KAPUSCINSKI, A [1 ]
QUACK, G [1 ]
机构
[1] MERZ & CO GMBH & CO,PRECLIN RES & DEV,D-60048 FRANKFURT,GERMANY
关键词
HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; THIOACETAMIDE; ORNITHINE; ASPARTATE; BRAIN UPTAKE INDEX;
D O I
10.1097/00001756-199402000-00002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
WE measured the brain uptake index (BUI) for radio-labelled L-ornithine (ORN) in rats with acute hepatic encephalopathy (HE) induced by two (onset stage) or three (comatous stage) administrations of a hepatotoxin-thioacetamide TAA). In the comatose group, an increase of the BUI to 275% of control was measured at 24 h post-treatment. In the onset group, the BUI for ORN increased gradually with time: it reached 220% of control at 7 days post-treatment and 442% of control at 21 days post-treatment. HE did not raise the BUI for a blood-brain barrier (BBB) non-penetrable amino acid L-aspartate (ASP), indicating that HE activates ORN transport but does not produce BBB leakage. ORN transport through BBB was not increased in rats with hyperammonemia comparable to that accompanying HE, but was induced without liver damage. Considering recent evidence that ORN acting intracerebrally ameliorates pathophysiological symptoms of HE, increased transport ORN across BBB should facilitate HE therapy based on systemic administration of this amino acid.
引用
收藏
页码:671 / 673
页数:3
相关论文
共 22 条
[1]   BRAIN CARBONIC-ANHYDRASE ACTIVITY IN RATS IN EXPERIMENTAL HEPATOGENIC ENCEPHALOPATHY [J].
ALBRECHT, J ;
HILGIER, W .
NEUROSCIENCE LETTERS, 1984, 45 (01) :7-10
[2]   ARGININE IN THIOACETAMIDE-INDUCED HEPATOGENIC ENCEPHALOPATHY IN RATS - ACTIVATION OF ENZYMES OF ARGININE METABOLISM TO GLUTAMATE [J].
ALBRECHT, J ;
HILGIER, W .
ACTA NEUROLOGICA SCANDINAVICA, 1986, 73 (05) :498-501
[3]   ACTIVATION OF ARGININE METABOLISM TO GLUTAMATE IN RAT-BRAIN SYNAPTOSOMES IN THIOACETAMIDE-INDUCED HEPATIC-ENCEPHALOPATHY - AN ADAPTATIVE RESPONSE [J].
ALBRECHT, J ;
HILGIER, W ;
RAFALOWSKA, U .
JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 25 (01) :125-130
[4]  
ALBRECHT J, 1988, BIOCH PATHOLOGY ASTR, P465
[5]  
ALBRECHT J, 1986, DYNAMIC PROPERTIES G, V2, P363
[6]   CEREBRAL GABAERGIC AND GLUTAMATERGIC FUNCTION IN HEPATIC-ENCEPHALOPATHY [J].
BUTTERWORTH, RF ;
LAVOIE, J ;
GIGUERE, JF ;
LAYRARGUES, GP ;
BERGERON, M .
NEUROCHEMICAL PATHOLOGY, 1987, 6 (1-2) :131-144
[7]   PLASMA AND CEREBROSPINAL-FLUID AMINO-ACID PATTERNS IN HEPATIC-ENCEPHALOPATHY [J].
CASCINO, A ;
CANGIANO, C ;
FIACCADORI, F ;
GHINELLI, F ;
MERLI, M ;
PELOSI, G ;
RIGGIO, O ;
FANELLI, FR ;
SACCHINI, D ;
STORTONI, M ;
CAPOCACCIA, L .
DIGESTIVE DISEASES AND SCIENCES, 1982, 27 (09) :828-832
[8]   BIOCHEMISTRY AND PHYSIOLOGY OF BRAIN AMMONIA [J].
COOPER, AJL ;
PLUM, F .
PHYSIOLOGICAL REVIEWS, 1987, 67 (02) :440-519
[9]   THE USE OF ORNITHINE SALTS OF BRANCHED-CHAIN KETOACIDS IN PORTAL-SYSTEMIC ENCEPHALOPATHY [J].
HERLONG, HF ;
MADDREY, WC ;
WALSER, M .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (04) :545-550
[10]  
HILGIER W, 1991, MOL CHEM NEUROPATHOL, V13, P47